BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12850759)

  • 1. [p53 mutations and resistance to chemotherapy: a stab in the back for p73?].
    Soussi T
    Bull Cancer; 2003 May; 90(5):383-6. PubMed ID: 12850759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations and resistance to chemotherapy: A stab in the back for p73.
    Soussi T
    Cancer Cell; 2003 Apr; 3(4):303-5. PubMed ID: 12726854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells.
    Nahor I; Abramovitch S; Engeland K; Werner H
    Growth Horm IGF Res; 2005 Dec; 15(6):388-96. PubMed ID: 16181796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitivity linked to p73 function.
    Irwin MS; Kondo K; Marin MC; Cheng LS; Hahn WC; Kaelin WG
    Cancer Cell; 2003 Apr; 3(4):403-10. PubMed ID: 12726865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73.
    Davis PK; Dowdy SF
    Int J Biochem Cell Biol; 2001 Oct; 33(10):935-9. PubMed ID: 11470228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family feud in chemosensitvity: p73 and mutant p53.
    Irwin MS
    Cell Cycle; 2004 Mar; 3(3):319-23. PubMed ID: 14739781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
    Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
    Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73 as a pharmaceutical target for cancer therapy.
    Bisso A; Collavin L; Del Sal G
    Curr Pharm Des; 2011; 17(6):578-90. PubMed ID: 21391908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting p73 in cancer.
    Maas AM; Bretz AC; Mack E; Stiewe T
    Cancer Lett; 2013 May; 332(2):229-36. PubMed ID: 21903324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.